MINIPRESS PFIZER 437 (Minipress 2 mg)
Generic Name: prazosin
Pill with imprint MINIPRESS PFIZER 437 is Pink & White, Capsule-shape and has been identified as Minipress 2 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.
Minipress is used in the treatment of benign prostatic hyperplasia; high blood pressure; heart failure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Minipress 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MINIPRESS PFIZER 437
Minipress
- Generic Name
- prazosin
- Imprint
- MINIPRESS PFIZER 437
- Strength
- 2 mg
- Color
- Pink & White
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, peripherally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer U.S. Pharmaceuticals Group
- Inactive Ingredients
-
FD&C Blue No. 1,
FD&C Red No. 3,
D&C Red No. 28,
FD&C Red No. 40,
magnesium stearate,
sodium lauryl sulfate,
sucrose
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00069-4370 (Discontinued) | Pfizer Inc. |
| 59762-5320 | Viatris |
| 54868-1290 (Discontinued) | Physicians Total Care Inc. (repackager) |
Related Images for "MINIPRESS PFIZER 437"
More about Minipress (prazosin)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (7)
- Drug images
- Pricing & coupons
- Generic availability
- En español
- Drug class: antiadrenergic agents, peripherally acting
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.